survivALL statistics

info info

Citations per year

Number of citations per year for the bioinformatics software tool survivALL
info

Tool usage distribution map

info info

Associated diseases

info

Popular tool citations

chevron_left Prognostic biomarker identification chevron_right
Want to access the full stats & trends on this tool?

survivALL specifications

Information


Unique identifier OMICS_23007
Name survivALL
Alternative name survivAPP
Software type Application/Script
Interface Web user interface
Restrictions to use None
Input data Measure data, Clinical data
Input format TXT
Computer skills Basic
Stability No
Maintained No

Maintainer


This tool is not available anymore.

Additional information


https://cran.r-project.org/web/packages/survivALL/survivALL.pdf

Information


Unique identifier OMICS_23007
Name survivALL
Alternative name survivAPP
Software type Application/Script
Interface Command line interface
Restrictions to use None
Operating system Unix/Linux, Mac OS, Windows
Programming languages R
License MIT License
Computer skills Advanced
Version 0.9.1
Stability No
Source code URL https://cran.r-project.org/src/contrib/survivALL_0.9.1.tar.gz
Maintained No

Download


download.png

Versioning


No version available

Maintainer


This tool is not available anymore.

Additional information


https://cran.r-project.org/web/packages/survivALL/survivALL.pdf

Publication for survivALL

survivALL citation

library_books

Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer

2012
PMCID: 3561608
PMID: 23378855
DOI: 10.5114/jcb.2012.32560

[…] pplicator surface. VBT was given over four weeks. No pelvic or vaginal relapse was observed after median follow-up time of 30 months. There were three abdominal failures. The estimated 5-year overall survivall was 93%. The 5-year disease-free survival was 87%. Bowel and urinary toxicities were not observed above grade 2. Two patients delivered vaginal stenosis (77 years old and 84 years old) [].An […]


Want to access the full list of citations?
survivALL institution(s)
Applied Bioinformatics of Cancer, University of Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Edinburgh, UK; Systems Immunology Group, Division of Genetics and Genomics, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, UK
survivALL funding source(s)
Supported by Breast Cancer Now, The Roslin Institute’s BBSRC Institute Strategic Program Grant (BBS/E/D/20211552), a Cancer Research UK PhD studentship, an Edinburgh College of Medicine and Veterinary Medicine and Edinburgh Global Research Scholarship.

survivALL reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review survivALL